Toronto’s Dr. Cameron Clokie’s Leading insight on Regenerative Medicine

Cameron Clokie is an established oral and maxillofacial surgeon and holds a Ph.D. in bone regeneration. He holds a doctorate in dental surgery with specialty training in the same. Clokie is the CEO of induce Biologics Inc a company based in Toronto Canada ensures that patients access cost effective bone regeneration solutions .Cameron experience and innovative method make him one of the most sought-after teacher and clinician. He has previously held the position of the head of oral and maxillofacial surgery and professor at Toronto University. Clokie has been a board member of several scientific advisory boards.

According to a recent interview, Clokie gives insight on regenerative medicine. Cameron says that stem cell therapy requires one to use cells that have been donated to treat a disease or injury. Clokie says that though the procedure sounds easy in reality, the procedure requires a lot of time and one to be careful. Regenerative medicine uses molecules and cells to fix the cells altered by injury or disease.

According to close regenerative therapy began with blood transfusion and later bone marrow transplant and now the ability to do cell therapy especially for patients with burns. Cell therapy is done using cells from a different part of the same patient. Clokie says that the above is a testament to how far regenerative medicine has developed. Clokie notes that regenerative medicine could increase life expectancy and improve the lives of people with chronic diseases. Cameron notes that though regenerative medicine has a lot of benefits it’s expensive to carry out and thus the implementation may take a while. Cameron notes that the procedure requires specialized facilities and very high-level experts to carry out the procedure making the procedure very expensive.

Cameron who is known as a serial entrepreneur has done a lot of address and writer a lot of publications on bone reconstruction and regeneration. Clokie holds more than 25 patents and has been able to train people on regenerative medicine. Cameron Clokie has been instrumental in making sure that regenerative medicine is known and though it will take he believes it’s the way to go.

Drew Madden Is More Than An Entrepreneur

Drew Madden has recently developed new ways to improve the healthcare system. He has done this by the technology he has created and continues to create on a monthly basis. Drew Madden has been amazed at all the recent technology that has evolved all over the United States. What has intrigued him the most are touchscreen applications. From the moment he encountered touchscreen devices, Drew Madden knew he wanted to distribute this technology to the medical field.

Drew Madden has recently created technology that allows doctors to touch the screen of a tablet and go through a patient’s information at a moment’s notice. This has been great for emergency situations that require past patient information to be brought forth immediately. Additionally, this technology is hospital-to=hospital friendly, which means doctors from one hospital can talk to doctors from other hospitals right through a touchscreen tablet.

Drew Madden studies medical systems at the Univerity of Iowa College of Engineering. He graduated at the top of his class. In addition to medical systems, Drew Madden also studied medical business. This allowed him to learn two important areas of the medical field. Drew’s learning helped him get a job at Nordic Consulting. At the time, Nordic Consulting was collapsing, and there were rumors of the firm shutting down. However, Drew Madden was able to bring Nordic Consulting back to life. In just under two years, Nordic went from a handful of clients to almost three hundred clients. This also opened up hundreds of jobs at Nordic. Nordic annual one-million dollar revenue quickly rose to one=hundred million+. After his great work at Nordic, Drew Madden felt the calling of starting his own business in the field of medical technology. His business has seen the most financial success of all time as it relates to technological companies.